This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hienonen, T. Articles by Aaltonen, L. A. Search for Related Content PubMed PubMed Citation Articles by Hienonen, T. Articles by Aaltonen, L. A.

Mutations in Two Short Noncoding Mononucleotide Repeats in Most Microsatellite-Unstable Colorectal Cancers

¹ Department of Medical Genetics, Biomedicum Helsinki and ² Department of Pathology, Haartman Institute, University of Helsinki; ³ Second Department of Surgery and ⁴ Department of Obstetrics and Gynecology and Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland; ⁵ The Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland; and ⁶ Department of Surgery, Jyväskylä Central Hospital, Jyväskylä, Finland

Requests for reprints: Lauri A. Aaltonen, Department of Medical Genetics, Biomedicum Helsinki, University of Helsinki, P.O. Box 63, FIN-00014 Helsinki, Finland. Phone: 358-9-1912-5595; Fax: 358-9-1912-5105; E-mail: lauri.aaltonen{at}helsinki.fi.

DNA mismatch repair (MMR)–deficient cells typically accumulate mutations in short repetitive DNA tracts. This microsatellite instability (MSI) facilitates malignant transformation when affecting genes with growth-related and caretaker functions. To date, several putative MSI target genes have been proposed mainly based on high mutation frequency within their coding regions. However, some intronic repeat mutations have also been suggested to associate with MSI tumorigenesis, indicating the need for additional analyses on noncoding repeats. Here we have analyzed an intronic T9 repeat of semenogelin I (SEMG1) and report mutation frequencies of 51% (75 of 146) and 62% (8 of 13) in MMR-deficient primary colorectal cancers and cell lines, respectively. The putative effect of the SEMG1 mutations was assessed by RNA and protein level analyses, but no differences were detected between colorectal cancer cell lines with different SEMG1 status. Subsequently, the general background mutation frequency of MSI colorectal cancers was assessed by screening for intergenic T9 repeat alterations. One of 10 examined repeats was mutated in 70% (102 of 145) of the colorectal cancers evaluated. The frequencies observed here are notably higher than previously published in noncoding repeats shorter than 10 bp in MMR-deficient primary tumors. Our results indicate that high mutation frequencies, similar or higher than those observed in proposed and approved target genes, can be detected in repeat tracts of MSI tumors without any apparent selection pressure. These data call for urgent and thorough large-scale evaluation of mutation frequencies in neutral short repetitive sequences in MMR-deficient tumors.

This article has been cited by other articles:

				P. Alhopuro, D. Phichith, S. Tuupanen, H. Sammalkorpi, M. Nybondas, J. Saharinen, J. P. Robinson, Z. Yang, L.-Q. Chen, T. Orntoft, et al. Unregulated smooth-muscle myosin in human intestinal neoplasia PNAS, April 8, 2008; 105(14): 5513 - 5518. [Abstract] [Full Text] [PDF]

				H. Sammalkorpi, P. Alhopuro, R. Lehtonen, J. Tuimala, J.-P. Mecklin, H. J. Jarvinen, J. Jiricny, A. Karhu, and L. A. Aaltonen Background Mutation Frequency in Microsatellite-Unstable Colorectal Cancer Cancer Res., June 15, 2007; 67(12): 5691 - 5698. [Abstract] [Full Text] [PDF]